Angel Invest Boston

Sal's Investment Syndicate: Click to Join Harvard’s Tom Eisenmann is the author of Why Startups Fail: A New Roadmap for Entrepreneurial Success. We discussed valuable lessons from the book and how they might apply to biotech startups. Highlights: Sal Daher Introduces Prof. Tom Eisenmann of the Harvard Business School, Author of Why Startups Fail Howard Stevenson’s 400X Return Contrasting Brad Feld’s Book with Prof. Tom Eisenmann’s Book Sal Daher’s Favorite Part of the Book: Failing “[failed] founders probably cycle through those. ...the Kubler Ross stages...” “...basically, half of failed founders come back and get back on the horse and do it again.” Shutting Down the Failed Venture, Gracefully The Number One Killer of Startups: False Starts “...engineers are particularly vulnerable to this because they want to build.” Sal Daher Discusses SQZ Biotech’s False Start and Brilliant Pivot The Origin Story of Why Startups Fail “...the factories that actually make this stuff actually generate enough cash to invest